magazine archive
magazine archive
News
Nomination of vaccine sceptic Robert F Kennedy Jnr sends healthcare shares into a spin
Thursday 21 Nov 2024The potential appointment of well-known vaccine sceptic Robert F Kennedy Jnr to the Trump cabinet in the role of head of the Department of Health and Human Services sent shivers through pharmaceutical companies on 14 November, with shares falling around 7% on average on both sides of the Atlantic...
Troubled semiconductor outfit IQE considers sale of Taiwan subsidiary
Thursday 21 Nov 2024After nearly 25 years of ups and downs on the stock market, compound semiconductor wafer supplier IQE (IQE:AIM) is at a real low point. The shares are trading at their lowest level in more than 15 years, after the company announced it would look to raise £15 million from its largest shareholder...
Shein IPO in sight as Amazon digs in for the long ‘Haul’
Thursday 21 Nov 2024A year after fast-fashion sensation Shein was first thought to have filed registration papers for a UK IPO, reports suggest the company is targeting the first quarter of 2025 for a London float that could value the business at £50 billion. Shein’s position as a fast-growing retailer expanding...
Retailers and hospitality firms bemoan budget cost burden
Thursday 14 Nov 2024Retail and hospitality companies have slammed the UK government’s Budget as a raid on corporate coffers that will heap extra costs on already hard-pressed sectors, with Labour’s 6.7% increase in the National Living Wage and uplift in employers’ national insurance contributions (NICs) forecast to...
Flyaway Palantir valuation reaches boiling point
Thursday 14 Nov 2024Crypto, gold, Donald Trump’s social media operation Trump Media & Technology (DJT:NASDAQ) have all been going gangbusters lately but if it’s momentum you’re after, you don’t get any hotter than Palantir (PLTR:NASDAQ) . Shares in the data analytics company have jumped 25% in the past five days (...
Why AstraZeneca shares remain in the doldrums despite raised outlook
Thursday 14 Nov 2024One might reasonably expect a company’s share price to rally when it delivers earnings ahead of consensus forecasts and raises its outlook, especially when the shares have dropped 25% heading into the numbers. That is not how things played out at the UK’s largest listed company AstraZeneca (AZN) on...
Second profit warning in a month send Vistry shares to 12-month low
Thursday 14 Nov 2024Housing developer Vistry (VTY) dealt shareholders another body-blow last week when it revealed (8 November) that charges for its understatement of costs on some sites would be higher than originally forecast. On 8 October, after an extensive internal review of its operations, the FTSE 100 firm...
Is Berkshire Hathaway’s record cash pile telling investors to be cautious?
Thursday 07 Nov 2024It is generally thought that owning shares in conglomerate Berkshire Hathaway (BRK-B:NYSE) is equivalent to holding a microcosm of the US economy, given the broad reach of its investments, from insurance to utilities and railroads. That notion is becoming more nuanced following the revelation by...
Markets eye further rate cuts ahead of inflation and consumer price data
Thursday 07 Nov 2024The economic landscape is set to become quieter in the run-up to Thanksgiving in the US and Christmas. At the time of going to press, the odds of the Federal Reserve making a quarter of a percentage point cut to interest rates is nailed on according to the CME’s Fedwatch tool. Likewise, the Bank of...
‘Magnificent Seven’ hand markets the good, the bad and the ugly
Thursday 07 Nov 2024Calendar third quarter earnings from the so-called ‘Magnificent Seven’ revealed a stark divide this year, with the tech giants delivering mixed results that are reshaping stock performance expectations. Of the six ‘Magnificent Seven’ stocks that have reported results already, the market didn’t like...